First Light Asset Management, LLC Dyne Therapeutics, Inc. Transaction History

First Light Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$23.56 - $35.55 $19.7 Million - $29.8 Million	-836,854 Reduced 66.56%	420,431 $9.91 Million
Q3 2024 Nov 14, 2024	BUY	$31.94 - $47.04 $27.9 Million - $41.2 Million	874,852 Added 228.76%	1,257,285 $45.2 Million
Q2 2024 Aug 14, 2024	BUY	$23.65 - $35.63 $6.54 Million - $9.85 Million	276,485 Added 260.96%	382,433 $13.5 Million
Q1 2024 May 15, 2024	BUY	$13.06 - $29.18 $1.38 Million - $3.09 Million	105,948 New	105,948 $3.01 Million
Q4 2020 Feb 16, 2021	SELL	$16.81 - $23.94 $420,249 - $598,500	-25,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$20.0 - $23.9 $500,000 - $597,500	25,000 New	25,000 $505,000

218

116M

322K

66.2K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $477M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.